SCHEMBL5338385

SCHEMBL5338385

CCCc1ccc(C(=O)NCc2cccs2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.67
RAB9A P51151 7/20 0.66
THRB P10828 1/20 0.60
ALDH1A1 P00352 4/20 0.60
PKM P14618 2/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
SMN1; SMN2 Q16637 5/20 0.58
NPC1 O15118 4/20 0.58
USP2 O75604 1/20 0.58
HTT P42858 1/20 0.58
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
MAPT P10636 2/20 0.54
KDM4E B2RXH2 1/20 0.54
GAA P10253 1/20 0.54
ALOX15 P16050 1/20 0.54
MAPK1 P28482 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PLK1 P53350 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18639513 0.92 HPGD (0.63) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL14842406 0.91 HPGD (0.62) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL5343669 0.88 NPC1 (0.73) HPGDRAB9AALDH1A1SMN1; SMN2NPC1
SCHEMBL507014 0.83 HPGD (0.70) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL13947125 0.82 HPGD (0.74) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL2234130 0.81 HPGD (1.00) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL12174596 0.80 NPC1 (0.74) HPGDRAB9AALDH1A1MEN1KMT2A
SCHEMBL13762085 0.80 HPGD (0.70) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL2400629 0.80 HPGD (0.74) HPGDRAB9ATHRBALDH1A1PKM
SCHEMBL5551614 0.80 HPGD (0.74) HPGDRAB9ATHRBALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
EP-1675844-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE Sterix Limited (GB) 2006-07-05 EP disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed
WO-2005042513-A1 PHENYL CARBOXAMIDE AND SULFONAMIDE DERIVATIVES FOR USE AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE STERIX LIMITED (GB) 2005-05-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 HPGD 340/4885RAB9A 3856/4885THRB 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.